BODILSENS SKOVSELSKAB ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.9% 1.3% 0.9% 1.3% 0.8%  
Credit score (0-100)  60 80 89 80 91  
Credit rating  BBB A A A AA  
Credit limit (kDKK)  0.0 143.4 782.7 130.6 931.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -318 -45.0 85.6 117 82.8  
EBITDA  -329 -60.2 77.0 109 75.5  
EBIT  -329 -300 -179 -115 -152  
Pre-tax profit (PTP)  -333.0 132.3 1,371.3 -1,278.9 1,713.3  
Net earnings  -259.2 146.2 1,070.7 -1,304.3 1,607.7  
Pre-tax profit without non-rec. items  -333 132 1,371 -1,279 1,713  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  9,731 10,418 10,349 10,125 10,265  
Shareholders equity total  8,476 9,420 10,350 9,046 10,653  
Interest-bearing liabilities  1,257 10,000 10,085 10,253 10,000  
Balance sheet total (assets)  9,977 19,665 20,954 19,462 21,321  

Net Debt  1,070 894 -511 954 -995  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -318 -45.0 85.6 117 82.8  
Gross profit growth  -36.0% 85.8% 0.0% 37.1% -29.4%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  9,977 19,665 20,954 19,462 21,321  
Balance sheet change%  -13.9% 97.1% 6.6% -7.1% 9.6%  
Added value  -328.5 -60.2 77.0 141.4 75.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -85 446 -325 -448 -89  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 -4.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  103.4% 666.1% -209.4% -97.9% -183.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -3.0% 2.2% 6.8% 0.2% 8.5%  
ROI %  -3.2% 2.2% 6.9% 0.2% 8.6%  
ROE %  -3.0% 1.6% 10.8% -13.4% 16.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  85.0% 47.9% 49.4% 46.5% 50.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -325.5% -1,483.7% -664.4% 875.7% -1,317.9%  
Gearing %  14.8% 106.2% 97.4% 113.3% 93.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.3% 3.4% 0.1% 13.0% 0.2%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.2 97.7 23.1 34.0 20.6  
Current Ratio  0.2 97.7 23.1 34.0 20.6  
Cash and cash equivalent  187.6 9,106.3 10,596.7 9,298.4 10,995.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,053.9 85.7 -380.9 -157.9 -404.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -329 -60 77 141 76  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -329 -60 77 109 76  
EBIT / employee  -329 -300 -179 -115 -152  
Net earnings / employee  -259 146 1,071 -1,304 1,608